Lemaitre Vascular market cap LMAT
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $1.9B
- Highest close in our data
- $2.6B
- Apr 2026
Lemaitre Vascular is worth $1.9B at the close on Nov 2, 2026, at $81.26 a share.
That is down 6% over the last year and up 56% over five years.
Its highest close in our data was $2.6B in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.9B | $1.8B | $2.6B | −2% |
| 2025 | $1.9B | $1.8B | $2.3B | −9% |
| 2024 | $2.1B | $1.2B | $2.4B | +65% |
| 2023 | $1.3B | $1B | $1.5B | +25% |
| 2022 | $1B | $895.6M | $1.2B | −8% |
| 2021 | $1.1B | $868.4M | $1.3B | +33% |
| 2020 | $823.9M | $55.8M | $823.9M | +1044% |
| 2019 | $72M | $68.5M | $705.2M | −84% |
| 2018 | $460.6M | $436.3M | $780.5M | −25% |
| 2017 | $613.4M | $412M | $742.1M | +30% |
| 2016 | $470.9M | $230.8M | $470.9M | +51% |
| 2015 | $312.5M | $132.2M | $312.5M | +138% |
| 2014 | $131.3M | $112.6M | $131.3M | +5% |
| 2013 | $124.9M | $88.8M | $133.3M | +41% |
| 2012 | $88.4M | $76.1M | $98.5M | −3% |
| 2011 | $91.2M | $83.7M | $110M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.
| Company | Market cap |
|---|---|
| LMATLemaitre Vascular | $1.9B |
| INSPInspire Medical Systems | $1.9B |
| UFPTUFP Technologies | $2.2B |
| EYENational Vision | $1.4B |
| CDRECadre | $1.3B |
| STAAStaar Surgical | $1.3B |
| WRBYWarby Parker | $2.9B |
| ATRCAtriCure | $3B |
| BVSBioventus | $1.1B |
| IARTIntegra Lifesciences | $1.1B |
| IRMDIradimed | $1B |
| Peer median | $1.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lemaitre Vascular
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.